Skip to content

Released Feb 29, 2016

10-K filed Feb 29, 2016, 60 days after period end · 0001162194-16-000182

Q4 2015 · 10-K
Revenue$30.72M−8.3% vs Q4 2014+7.3% vs Q3 2015
Net Income-$12.88MderivedN/M vs Q4 2014N/M vs Q3 2015
EPS Diluted-$0.45N/M vs Q4 2014N/M vs Q3 2015
Operating Incomederived-$13,692,000N/M
Operating Cash Flowderived-$4,404,000N/M
Free Cash Flowderived-$5,841,000N/M
Margins · derived
Operating margin-44.6%−15.2 pt vs Q4 2014
Net margin-41.9%−9.2 pt vs Q4 2014

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-K.

Same quarter

MetricQ4 2015Q4 2014Q4 2013Q4 2012
Revenue$30.72M$33.49M$20.88M$15.66M
Net Income-$12.88M-$10.94M-$4.64M-$3.60M
EPS Diluted-$0.45-$0.39-$0.18-$0.14

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Standard Biotools Inc. · CIK 1162194 · Engraved from SEC EDGAR